Related Experiment Video
Updated: Jul 11, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Risk of Lymphoma in Inflammatory Bowel Disease
1Dr. Siegel serves as Director of the Inflammatory Bowel Disease Center in the Section of Gastroenterology and Hepatology at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
Abstract:
The risk of lymphoma associated with inflammatory bowel disease is a cause of great anxiety for patients, their families, and their providers. Trepidation regarding the use of immunomodulators and anti-tumor necrosis factor agents, due to their possible association with lymphoma, may influence treatment decisions, compliance with prescribed medications, and, possibly, long-term outcomes if appropriate medical therapy is avoided. Lymphoma is a difficult topic to discuss with patients due to uncertainty regarding the absolute risk. A general message to convey to patients is that there is likely an increased risk of lymphoma associated with the treatment of inflammatory bowel disease but that the substantial benefit of these therapies outweighs the very small risk incurred. This review aims to explain current data regarding the risk of lymphoma associated with inflammatory bowel disease itself and the immune suppressant therapy used for its treatment.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

